Cargando…
Increased actin binding is a shared molecular consequence of numerous spinocerebellar ataxia mutations in β-III-spectrin
Spinocerebellar ataxia type 5 (SCA5) is a neurodegenerative disease caused by mutations in the SPTBN2 gene encoding the cytoskeletal protein β-III-spectrin. Previously, we demonstrated that a L253P missense mutation, localizing to the β-III-spectrin actin-binding domain (ABD), causes increased actin...
Autores principales: | Atang, Alexandra E., Keller, Amanda R., Denha, Sarah A., Avery, Adam W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980045/ https://www.ncbi.nlm.nih.gov/pubmed/36865188 http://dx.doi.org/10.1101/2023.02.20.529285 |
Ejemplares similares
-
Increased Actin Binding Is a Shared Molecular Consequence of Numerous SCA5 Mutations in β-III-Spectrin
por: Atang, Alexandra E., et al.
Publicado: (2023) -
Early-phase drug discovery of β-III-spectrin actin-binding modulators for treatment of spinocerebellar ataxia type 5
por: Guhathakurta, Piyali, et al.
Publicado: (2023) -
β-III-spectrin N-terminus is required for high-affinity actin binding and SCA5 neurotoxicity
por: Denha, Sarah A., et al.
Publicado: (2022) -
Novel drug discovery platform for spinocerebellar ataxia, using fluorescence technology targeting β-III-spectrin
por: Rebbeck, Robyn T., et al.
Publicado: (2020) -
A human β-III-spectrin spinocerebellar ataxia type 5 mutation causes high-affinity F-actin binding
por: Avery, Adam W., et al.
Publicado: (2016)